MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Trevi Therapeutics, Inc. Common Stock

TRVI

#1766
Trevi Therapeutics, Inc. Common Stock
11.92
+6.81%
Sector:
Base:
Profit Currency:
Daily Range
11.92
11.92
Year Range
4.17
14.39
Daily Change
+6.81%
Monthly Change
+8.96%
6 month change
+46.08%
Year Change
+185.85%
Previous Close
11.16
Open
11.92
Bid
Ask
Low
11.92
High
11.92
Volume
112
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. TRVI
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
TRVI
2026.01.22
Trevi’s nalbuphine ER shows significant reduction in IPF cough
Investing Investing
TRVI
2026.01.08
Trevi Therapeutics schedules FDA meeting for chronic cough program
Benzinga Benzinga
IMRX ELME ERAS PHAT UMC
2026.01.08
Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Canadian Solar (NASDAQ:CSIQ), Elme (NYSE:ELME)
Investing Investing
TRVI
2025.12.19
Trevi Therapeutics stock price target raised to $18 by Stifel on cough drug potential
Investing Investing
TRVI
2025.12.10
Trevi Therapeutics stock hits all-time high of 14.01 USD
Investing Investing
TRVI
2025.12.04
Trevi Therapeutics appoints David Hastings as new CFO
Seeking Alpha Seeking Alpha
TRVI
2025.12.03
Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And More (TRVI)
Investing Investing
TRVI
2025.12.03
Trevi Therapeutics stock hits all-time high at 13.92 USD
Investing Investing
AA DELL ORCL WMT MU
2025.11.26
Oracle, AMD among market cap stock movers on Wednesday
Investing Investing
TRVI
2025.11.26
Trevi Therapeutics stock hits all-time high at 12.31 USD
Investing Investing
TRVI
2025.11.19
Leerink Partners raises Trevi Therapeutics stock price target to $16 on Haduvio outlook
Investing Investing
TRVI
2025.11.14
Cantor Fitzgerald reiterates Overweight rating on Trevi Therapeutics stock

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd